A source-linked view of every Plecanatide study in the current snapshot—status, phase, enrollment, results, publications, locations and changes over time.
Largest indexed study
2,370 participants · NCT01919697 →Developer / research origin
Synergy Pharmaceuticals
Evidence summary
Plecanatide appears in 15 indexed studies: 0 recruiting, 14 completed and 11 with registry results posted. The highest registered development stage in this snapshot is Phase 3. These counts measure registry activity; they do not establish that Plecanatide is safe or effective.
Review the design, endpoints, population, protocol changes, statistical analysis and publications before drawing conclusions.
Current studies
Completed studies
Stopped studies
Bausch Health Americas, Inc. · Functional Constipation (FC)
Phase 2
Active, not recruiting
180
2026-07
University of Wisconsin, Madison · Barrett Esophagus · Gastroesophageal Reflux Disease
Phase 1
Completed
43
2026-04
Bausch Health Americas, Inc. · Irritable Bowel Syndrome With Constipation
Phase 2
Completed
218
2025-12
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. · Functional Constipation
Phase 3
Completed
648
2024-07
Bausch Health Americas, Inc. · Irritable Bowel Syndrome
Phase 3
Completed
2,272
2020-08
Bausch Health Americas, Inc. · Chronic Idiopathic Constipation
Phase 2
Completed
84
2020-01
Bausch Health Americas, Inc. · Chronic Idiopathic Constipation
Phase 3
Completed
1,394
2019-12
Full study index
Add status, phase, condition, country, result and publication filters inside this molecule’s indexed study set.
15 matching studies
Last registry update first
Latest publications
Related pages
Commercial research listings, where present, are kept separate from clinical evidence and are not treatment recommendations.